Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7

Molecular and Cellular Endocrinology

Volumn 205, Issue 1-2, 2003, Pages 121-129

  Tou, Liqiang ^a   Quibria, Naureen ^a   Alexander, Joseph M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Alkaline phosphatase; AP 1; BMP 7; Cbfa1; OSE2; Osteoblast

Indexed keywords

CIS ACTING ELEMENT; CORE BINDING FACTOR; CORE BINDING FACTOR 1; LUCIFERASE; OSTEOGENIC PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOREGULATION; CELL CLONE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; DNA FLANKING REGION; GENE CONSTRUCT; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC STRAIN; GENETIC TRANSCRIPTION; HUMAN; MUTATIONAL ANALYSIS; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 0142029486     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(03)00151-5     Document Type: Article

References (40)

1. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:1991;2499.
2. Banerjee C., Javed A., Choi J.-Y., Green J., Rosen V., van Wijnen A.J., Stein J., Lian J.B., Stein G.S. Differential regulation of the two principal Runx2/Cbfa1 N-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenot. Endocrinology. 142:2001;4026-4039.
3. Celeste A.J., Iannazzi J.A., Taylor R.C., Hewick R.M., Rosen V., Wang E.A., Wozney J.M. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. USA. 87:1990;9843-9847.
4. Drissi H., Luc Q., Shakoori R., Chuva De Sousa Lopes S., Choi J.Y., Terry A., Hu M., Jones S., Neil J.C., Lian J.B., Stein J.L., Van Wijnen A.J., Stein G.S. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J. Cell. Physiol. 184:2000;341-350.
5. Ducy P., Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15:1995;1858-1869.
6. Ducy P., Karsenty G. Genetic control of cell differentiation in the skeleton. Curr. Opin. Cell. Biol. 10:1998;614-619.
7. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation [see comments]. Cell. 89:1997;747-754.
8. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., Amling M., Karsenty G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13:1999;1025-1036.
9. Franceschi R.T. The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit. Rev. Oral. Biol. Med. 10:1999;40-57.
10. Franceschi R.T., Xiao G. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J. Cell. Biochem. 88:2003;446-454.
11. Geoffroy V., Ducy P., Karsenty G. A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J. Biol. Chem. 270:1995;30973-30979.
12. Geoffroy V., Corral D.A., Zhou L., Lee B., Karsenty G. Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function. Mamm. Genome. 9:1998;54-57.
13. Gori F., Thomas T., Hicok K.C., Spelsberg T.C., Riggs B.L. Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J. Bone Miner. Res. 14:1999;1522-1535.
14. Heldin C.H., Miyazono K., ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471.
15. Hijiya N., Setoguchi M., Matsuura K., Higuchi Y., Akizuki S., Yamamoto S. Cloning and characterization of the human osteopontin gene and its promoter. Biochem. J. 303:1994;255-262.
16. Hu P.P., Datto M.B., Wang X.F. Molecular mechanisms of transforming growth factor-beta signaling. Endocr. Rev. 19:1998;349-363.
17. Ji C., Casinghino S., Chang D.J., Chen Y., Javed A., Ito Y., Hiebert S.W., Lian J.B., Stein G.S., McCarthy T.L., Centrella M. CBFa(AML/PEBP2) -related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J. Cell. Biochem. 69:1998;353-563.
18. Jonk L.J., Itoh S., Heldin C.H., ten Dijke P., Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273:1998;21145-21152.
19. Karsenty, G., 1998. Transcriptional regulation of osteoblast differentiation during development. Front Biosci. Aug 1;3:D834-D837.
20. Katagiri T., Yamaguchi A., Ikeda T., Yoshiki S., Wozney J.M., Rosen V., Wang E.A., Tanaka H., Omura S., Suda T. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem. Biophys. Res. Commun. 172:1990;295-299.
21. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell. Biol. 127:1994;1755-1766. [published erratum appears in J. Cell. Biol. 1995 Feb;128(4):following 713].
22. Komori T., Kishimoto T. Cbfa1 in bone development. Curr. Opin. Genet. Dev. 8:1998;494-499.
23. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts [see comments]. Cell. 89:1997;755-764.
24. Lee M.H., Javed A., Kim H.J., Shin H.I., Gutierrez S., Choi J.Y., Rosen V., Stein J.L., van Wijnen A.J., Stein G.S., Lian J.B., Ryoo H.M. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J. Cell. Biochem. 73:1999;114-125.
25. Lee K., Kim H., Li Q., Chi X., Ueta C., Komori T., Wozney J., Kim E., Choi J., Ryoo H., Bae S. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol. 20:2000;8783-8792.
26. Lee, K.S., Hong, S.H., Bae, S.C., 2002. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene Oct. 17;21(47):7156-7163.
27. Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., Lindhout D., Cole W.G., Henn W., Knoll J.H., Owen M.J., Mertelsmann R., Zabel B.U., Olsen B.R. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia [see comments]. Cell. 89:1997;773-779.
28. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development [see comments]. Cell. 89:1997;765-771.
29. Rossert J.A., Chen S.S., Eberspaecher H., Smith C.N., de Crombrugghe B. Identification of a minimal sequence of the mouse pro-alpha 1(I) collagen promoter that confers high-level osteoblast expression in transgenic mice and that binds a protein selectively present in osteoblasts. Proc. Natl. Acad. Sci. USA. 93:1996;1027-1031.
30. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F., White K.H., Coughlin J.E., Tucker M.M., Pang R.H., et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267:1992;20352-20362.
31. Shen Z., Nakamoto T., Tsuji K., Nifuji A., Miyazono K., Komori T., Hirai H., Noda M. Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts. J. Biol. Chem. 277:2002;29840-29846.
32. Stewart M., Terry A., Hu M., O'Hara M., Blyth K., Baxter E., Cameron E., Onions D.E., Neil J.C. Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc. Natl. Acad. Sci. USA. 94:1997;8646-8651.
33. Tsuji K., Ito Y., Noda M. Expression of the PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells. Bone. 22:1998;87-92.
34. Urist M.R. Bone: formation by autoinduction. Science. 150:1965;893-899.
35. Viereck V., Siggelkow H., Tauber S., Raddatz D., Schutze N., Hufner M. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts. J. Cell. Biochem. 86:2002;348-356.
36. Wang E.A., Rosen V., Cordes P., Hewick R.M., Kriz M.J., Luxenberg D.P., Sibley B.S., Wozney J.M. Purification and characterization of other distinct bone-inducing factors. Proc. Natl. Acad. Sci. USA. 85:1988;9484-9488.
37. Xiao Z.S., Thomas R., Hinson T.K., Quarles L.D. Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene. 214:1998;187-197.
38. Xiao G., Jiang D., Thomas P., Benson M.D., Guan K., Karsenty G., Franceschi R.T. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J. Biol. Chem. 275:2000;4453-4459.
39. Xiao Z., Sg L., Hinson T., Quarles L. Characterization of the upstream mouse Cbfa1/Runx2 promoter. J. Cell. Biochem. 82:2001;647-659.
40. Yeh L.C., Tsai A.D., Lee J.C. Osteogenic protein-1 (OP-1) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. J. Cell. Biochem. 87:2002;292-304.